COVID-19 Effectiveness Study in the Philippines

University of the Philippines3,000 enrolled

Overview

This is a multi-site, observational, prospective test negative design case-control study which primarily aims to determine the protective effectiveness of 2 doses of an inactivated COVID-19 vaccine at least 14 days after the second dose, against hospitalized virologically-confirmed SARS-CoV-2 infection.

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

COVID-19 Vaccine Effectiveness Against COVID-19 Hospitalized COVID-19

Interventions

no interventionOTHER

no intervention

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Written informed consent. * Aged 18 years of age and above * Residing in the catchment area of the participating hospital * Admitted to the participating hospital with an acute respiratory illness * Able and willing to provide a naso- and oro-pharyngeal swab for RT-PCR testing Exclusion Criteria: * 6.2.2.1 Refusal to participate

Locations (1)

Vicente Sotto Memorial Medical Center

Cebu City, Cebu Province, Philippines

RECRUITING

Outcomes

Primary Outcomes

Number of hospitalized virologically-confirmed SARS-CoV-2 infection

Time frame: 1 year

Central Contacts

Kristal An C Agrupis, MD, MSc

CONTACT

+63 2 8559 0199 kcagrupis@up.edu.ph

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.